III. Contraindications

  1. Narrow-angle Glaucoma
  2. Concurrent MAO inhibitor use

IV. Precautions

  1. Increased Suicidality in children and teens (FDA black box warning)

V. Mechanism

  1. Selective Norepinephrine reuptake inhibitor
  2. Non-stimulant (not a controlled substance)

VI. Pharmacokinetics

  1. Peak serum concentration
    1. Without food: 1 hour
    2. With food: 3 hours
  2. Metabolized by CYP2D6
  3. Half-life
    1. Most patients: 5 hours
    2. CYP2D6 defect (5-10%): 24 hours
  4. Adjust dose to 50% if Hepatic dysfunction

VII. Dosing: Indicated for ADHD in Age 6 years and older

  1. Timing
    1. Once daily dosing or
    2. Split daily dose to bid (morning and late afternoon)
  2. Weight <70 kg
    1. Initial: 0.5 mg/kg/day
    2. Increase after 3 days to 1.2 mg/kg/day
      1. Delay increasing dose if on CYP2D6 inhibitor
      2. See Drug Interactions below
    3. Maximum: 1.4 mg/kg/day up to 100 mg
  3. Weight >70 kg
    1. Initial: 40 mg/day
    2. Increase after 3 days to 80 mg/day
      1. Delay increasing dose if on CYP2D6 inhibitor
      2. See Drug Interactions below
    3. Maximum: 100 mg/day or 1.4 mg/kg

VIII. Efficacy: Not considered a first line agent

IX. Adverse Effects

  1. Severe liver injury
    1. Serious reactions, but case reports only as of 2005
    2. Observe clinically, but no routine LFT monitoring
    3. (February 2005) Prescriber's Letter, p. 8
  2. Abdominal Pain
  3. Gastrointestinal upset
    1. Nausea
    2. Vomiting (more than with Methylphenidate)
  4. Diminished appetite
  5. Dizziness
  6. Somnolence (more than with Methylphenidate)
  7. Weight loss (3.5% weight loss in 20% of patients)
  8. Anticholinergic effects in adults
    1. Dry Mouth
    2. Constipation
    3. Urinary Retention
    4. Sexual Dysfunction

X. Drug Interactions

  1. MAO inhibitor
  2. Concurrent use of potent CYP2D6 inhibitors
    1. Paroxetine (Paxil)
    2. Fluoxetine (Prozac)
    3. Quinidine

XI. Preparations

  1. Capsules: 10 mg, 18 mg, 25 mg, 40 mg, 60 mg

XII. References

  1. (2003) Lexi-Comp Drug Database for Pocket PC (7/9/03)
  2. (2003) Med Lett Drugs Ther 45(1149):11-2 [PubMed]

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window

Cost: Medications

strattera (on 1/18/2017 at Medicaid.Gov Survey of pharmacy drug pricing)
STRATTERA 10 MG CAPSULE $12.68 each
STRATTERA 100 MG CAPSULE $14.81 each
STRATTERA 18 MG CAPSULE $12.64 each
STRATTERA 25 MG CAPSULE $12.64 each
STRATTERA 40 MG CAPSULE $13.74 each
STRATTERA 60 MG CAPSULE $13.75 each
STRATTERA 80 MG CAPSULE $14.88 each

Ontology: atomoxetine (C0076823)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C041930
SnomedCT 407038000, 407037005
LNC LP33297-0, MTHU016626
English Tomoxetine, atomoxetine [Chemical/Ingredient], ATOMOXETINE, Atomoxetine (product), Atomoxetine (substance), Atomoxetine, tomoxetine, atomoxetine
Spanish atomoxetina (producto), atomoxetina (sustancia), atomoxetina

Ontology: Strattera (C1176420)

Definition (CHV) a drug used to treat attention deficit hyperactivity disorder (ADHD)
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C041930
SnomedCT 407039008
English strattera, Strattera (product), Strattera, Lilly brand of atomoxetine hydrochloride
Spanish Strattera, Strattera (producto)